Preferential Survival of an MBP-Specific T Cell Clone in an HLA-DR2 Multiple Sclerosis Patient

Publisher： Karger

E-ISSN： 1423-0216|10|1|1-4

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.10, Iss.1, 2002-08, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunological Study of IFNβ-1a-Treated and Untreated Multiple Sclerosis Patients: Clarifying IFNβ Mechanisms and Establishing Specific Dendritic Cell Immunotherapy

By  

Neuroimmunomodulation, Vol. 12, Iss. 1, 2005-03 ,pp. : 29-44

Karger

Access to resources Recommend Favorite

TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 20, Iss. 3, 2013-04 ,pp. : 177-183

Karger

Access to resources Recommend Favorite

Association of HLA-DR, -DQ Genotype and CTLA-4 Gene Polymorphism with Graves’ Disease in Japanese Children

By  

Hormone Research in Paediatrics, Vol. 63, Iss. 2, 2005-04 ,pp. : 55-60

Karger

Access to resources Recommend Favorite

Thymus-Derived Glucocorticoids and the Regulation of Antigen-Specific T-Cell Development

By  

Neuroimmunomodulation, Vol. 6, Iss. 1-2, 1999-01 ,pp. : 90-96

Karger

Access to resources Recommend Favorite

Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications

By  

Neuroimmunomodulation, Vol. 22, Iss. 3, 2014-05 ,pp. : 181-195

Karger

Access to resources Recommend Favorite